Accès gratuit
J. Soc. Biol.
Volume 203, Numéro 4, 2009
Page(s) 295 - 302
Section Comment et pourquoi s'est construit le système rénine-angiotensine au cours de l'évolution ?How and why did the renin-angiotension sytem build up during evolution?
Publié en ligne 1 février 2010
  • Audoly L.P., Oliverio M.I., Coffman T.M., Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting. Trends Endocrinol Metab, 2000, 11, 263-269. [CrossRef] [PubMed] [Google Scholar]
  • Billet S., Bardin S., Tacine R., Clauser E., Conchon S., The AT1A receptor “gain-of-function” mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II. Am J Physiol Endocrinol Metab, 2006, 290, E840-848. [Google Scholar]
  • Billet S., Bardin S., Verp S., Baudrie V., Michaud A., Conchon S., Muffat-Joly M., Escoubet B., Souil E., Hamard G., Bernstein K.E., Gasc J.M., Elghozi J.L., Corvol P., Clauser E., Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J Clin Invest, 2007, 117, 1914-1925. [CrossRef] [PubMed] [Google Scholar]
  • Bockaert J., Pin J.P., Molecular tinkering of G protein-coupled receptors: an evolutionary success. Embo J, 1999, 18, 1723-1729. [CrossRef] [PubMed] [Google Scholar]
  • Chattopadhyay N., Mithal A., Brown E.M., The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev, 1996, 17, 289-307. [PubMed] [Google Scholar]
  • Clauser E., Curnow K.M., Conchon S., Davies E., Teutsch B., Vianello B., Monnot C., Corvol P., Molecular structure and mechanisms of action of mammalian angiotensin II receptors. Cur Op Endocrinol Diab, 1995, 2, 404-411. [CrossRef] [Google Scholar]
  • Clauser E., Curnow K.M., Davies E., Conchon S., Teutsch B., Vianello B., Monnot C., Corvol P., Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol, 1996, 134, 403-411. [Google Scholar]
  • Conchon S., Barrault M.B., Miserey S., Corvol P., Clauser E., The C-terminal third intracellular loop of the rat ATFormula angiotensin II receptor plays a key role in G protein coupling specificity and transduction of the mitogenic signal. J Biol Chem, 1997, 272, 25566-25572. [Google Scholar]
  • Conn P.M., Ulloa-Aguirre A., Ito J., Janovick J.A., G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev, 2007, 59, 225-250. [CrossRef] [PubMed] [Google Scholar]
  • Davies E., Bonnardeaux A., Plouin P.F., Corvol P., Clauser E., Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab, 1997, 82, 611-615. [CrossRef] [PubMed] [Google Scholar]
  • Dufour C., Casane D., Denton D., Wickings J., Corvol P., Jeunemaitre X., Human-chimpanzee DNA sequence variation in the four major genes of the renin angiotensin system. Genomics, 2000, 69, 14-26. [CrossRef] [PubMed] [Google Scholar]
  • Fredriksson R., Lagerstrom M.C., Schioth H.B., Expansion of the superfamily of G-protein-coupled receptors in chordates. Ann N Y Acad Sci, 2005, 1040, 89-94. [CrossRef] [PubMed] [Google Scholar]
  • Gasc J.M., Shanmugam S., Sibony M., Corvol P., Tissue specific expression of type1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension, 1994, 24, 531-537. [PubMed] [Google Scholar]
  • Groblewski T., Maigret B., Larguier R., Lombard C., Bonnafous J.C., Marie J., Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation. J Biol Chem, 1997, 272, 1822-1826. [CrossRef] [PubMed] [Google Scholar]
  • Gu Z., Cavalcanti A., Chen F.C., Bouman P., Li W.H., Extent of gene duplication in the genomes of Drosophila, nematode, and yeast. Mol Biol Evol, 2002, 19, 256-262. [PubMed] [Google Scholar]
  • Hunyady L., Catt K.J., Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol, 2006, 20, 953-970. [Google Scholar]
  • Inoue Y., Nakamura N., Inagami T., A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J Hypertens, 1997, 15, 703-714. [CrossRef] [PubMed] [Google Scholar]
  • Ji H., Sandberg K., Zhang Y., Catt K.J., Molecular cloning, sequencing and functional expression of an amphibian angiotensin II receptor. Biochem Biophys Res Com, 1993, 194, 756-762. [CrossRef] [Google Scholar]
  • Josefsson L.G., Evidence for kinship between diverse G-protein coupled receptors. Gene, 1999, 239, 333-340. [CrossRef] [PubMed] [Google Scholar]
  • Langley J.N., On the reaction of cells and of nerve endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol, 1905, 33, 374–413. [PubMed] [Google Scholar]
  • McLysaght A., Hokamp K., Wolfe K.H., Extensive genomic duplication during early chordate evolution. Nat Genet, 2002, 31, 200-204. [Google Scholar]
  • Morello J.P., Bichet D.G., Nephrogenic diabetes insipidus. Annu Rev Physiol, 2001, 63, 607-630. [CrossRef] [PubMed] [Google Scholar]
  • Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G., Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature, 1993, 365, 649-651. [CrossRef] [PubMed] [Google Scholar]
  • Parnot C., Bardin S., Miserey-Lenkei S., Guedin D., Corvol P., Clauser E., Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay. Proc Natl Acad Sci USA, 2000, 97, 7615-7620. [CrossRef] [Google Scholar]
  • Perez D.M., From plants to man: the GPCR “tree of life”. Mol Pharmacol, 2005, 67, 1383-1384. [Google Scholar]
  • Porrello E.R., Delbridge L.M., Thomas W.G., The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front Biosci, 2009, 14, 958-972. [CrossRef] [PubMed] [Google Scholar]
  • Rao V.R., Oprian D.D., Activating mutations of rhodopsin and other G protein-coupled receptors. Annu Rev Biophys Biomol Struct, 1996, 25, 287-314. [PubMed] [Google Scholar]
  • Sandberg K., Ji H., Clark A.J., Shapira H., Catt K.J., Cloning and expression of a novel angiotensin II receptor subtype. J. Biol. Chem., 1992, 267, 9455-9458. [Google Scholar]
  • Schipani E., Kruse K., Juppner H., A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science, 1995, 268, 98-100. [CrossRef] [PubMed] [Google Scholar]
  • Servant G., Laporte S.A., Leduc R., Escher E., Guillemette G., Identification of Angiotensin II binding domains in the rat AT2 receptor with photolabile angiotensin analogs. J Biol Chem, 1997, 272, 8653-8659. [Google Scholar]
  • Shenker A., Laue L., Kosugi S., Merendino J.J.J., Minegishi T., Cutler G.B.J., A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature, 1993, 365, 652-654. [Google Scholar]
  • Tian Y., Baukal A.J., Sandberg K., Bernstein K.E., Balla T., Catt K.J., Properties of AT1a and AT1b angiotensin receptors expressed in adrenocortical Y-1 cells. Am J Physiol, 1996, 270, E831-E839. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.